1.Clinical Score System to Differentiate Severe Fever with Thrombocytopenia Syndrome Patients from Patients with Scrub Typhus or Hemorrhagic Fever with Renal Syndrome in Korea
Dae Hyuk HEO ; Yu Min KANG ; Kyoung Ho SONG ; Jun Won SEO ; Jeong Han KIM ; June Young CHUN ; Kang Il JUN ; Chang Kyung KANG ; Song Mi MOON ; Pyoeng Gyun CHOE ; Wan Beom PARK ; Ji Hwan BANG ; Eu Suk KIM ; Hong Bin KIM ; Sang Won PARK ; Won Sup OH ; Nam Joong KIM ; Myoung don OH
Journal of Korean Medical Science 2020;35(11):77-
BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high mortality in East Asia. This study aimed to develop, for primary care providers, a prediction score using initial symptoms and basic laboratory blood tests to differentiate between SFTS and other endemic zoonoses in Korea.METHODS: Patients aged ≥ 18 years diagnosed with endemic zoonoses during a 3-year period (between January 2015 and December 2017) were retrospectively enrolled from 4 tertiary university hospitals. A prediction score was built based on multivariate logistic regression analyses.RESULTS: Of 84 patients, 35 with SFTS and 49 with other endemic zoonoses were enrolled. In multivariate logistic regression analysis, independent predictors of SFTS included neurologic symptoms (odds ratio [OR], 12.915; 95% confidence interval [CI], 2.173–76.747), diarrhea (OR, 10.306; 95% CI, 1.588–66.895), leukopenia (< 4,000/mm3) (OR, 19.400; 95% CI, 3.290–114.408), and normal C-reactive protein (< 0.5 mg/dL) (OR, 24.739; 95% CI, 1.812–337.742). We set up a prediction score by assigning one point to each of these four predictors. A score of ≥ 2 had 82.9% sensitivity (95% CI, 71.7%–87.5%) and 95.9% specificity (95% CI, 88.0%–99.2%). The area under the curve of the clinical prediction score was 0.950 (95% CI, 0.903–0.997).CONCLUSION: This study finding suggests a simple and useful scoring system to predict SFTS in patients with endemic zoonoses. We expect this strategic approach to facilitate early differentiation of SFTS from other endemic zoonoses, especially by primary care providers, and to improve the clinical outcomes.
2.Clinical Score System to Differentiate Severe Fever with Thrombocytopenia Syndrome Patients from Patients with Scrub Typhus or Hemorrhagic Fever with Renal Syndrome in Korea
Dae Hyuk HEO ; Yu Min KANG ; Kyoung Ho SONG ; Jun Won SEO ; Jeong Han KIM ; June Young CHUN ; Kang Il JUN ; Chang Kyung KANG ; Song Mi MOON ; Pyoeng Gyun CHOE ; Wan Beom PARK ; Ji Hwan BANG ; Eu Suk KIM ; Hong Bin KIM ; Sang Won PARK ; Won Sup OH ; Nam Joong KIM ; Myoung don OH
Journal of Korean Medical Science 2020;35(11):e77-
BACKGROUND:
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high mortality in East Asia. This study aimed to develop, for primary care providers, a prediction score using initial symptoms and basic laboratory blood tests to differentiate between SFTS and other endemic zoonoses in Korea.
METHODS:
Patients aged ≥ 18 years diagnosed with endemic zoonoses during a 3-year period (between January 2015 and December 2017) were retrospectively enrolled from 4 tertiary university hospitals. A prediction score was built based on multivariate logistic regression analyses.
RESULTS:
Of 84 patients, 35 with SFTS and 49 with other endemic zoonoses were enrolled. In multivariate logistic regression analysis, independent predictors of SFTS included neurologic symptoms (odds ratio [OR], 12.915; 95% confidence interval [CI], 2.173–76.747), diarrhea (OR, 10.306; 95% CI, 1.588–66.895), leukopenia (< 4,000/mm3) (OR, 19.400; 95% CI, 3.290–114.408), and normal C-reactive protein (< 0.5 mg/dL) (OR, 24.739; 95% CI, 1.812–337.742). We set up a prediction score by assigning one point to each of these four predictors. A score of ≥ 2 had 82.9% sensitivity (95% CI, 71.7%–87.5%) and 95.9% specificity (95% CI, 88.0%–99.2%). The area under the curve of the clinical prediction score was 0.950 (95% CI, 0.903–0.997).
CONCLUSION
This study finding suggests a simple and useful scoring system to predict SFTS in patients with endemic zoonoses. We expect this strategic approach to facilitate early differentiation of SFTS from other endemic zoonoses, especially by primary care providers, and to improve the clinical outcomes.
3.Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-beta-induced alveolar epithelial to mesenchymal transition.
Jeong Sup SONG ; Chun Mi KANG ; Chan Kwon PARK ; Hyung Kyu YOON ; Sook Young LEE ; Joong Hyun AHN ; Hwa Sik MOON
Experimental & Molecular Medicine 2011;43(9):517-524
Idiopathic pulmonary fibrosis (IPF) is a lethal parenchymal lung disease characterized by myofibroblast proliferation. Alveolar epithelial cells (AECs) are thought to produce myofibroblasts through the epithelial to mesenchymal transition (EMT). Receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily of cell surface receptors whose activation is associated with renal fibrosis during diabetes and liver fibrosis. RAGE is expressed at low basal levels in most adult tissues except the lung. In this study, we evaluated the interaction of ligand advanced glycation end products (AGE) with RAGE during the epithelial to myofibroblast transition in rat AECs. Our results indicate that AGE inhibited the TGF-beta-dependent alveolar EMT by increasing Smad7 expression, and that the effect was abolished by RAGE siRNA treatment. Thus, the induction of Smad7 by the AGE-RAGE interaction limits the development of pulmonary fibrosis by inhibiting TGF-beta-dependent signaling in AECs.
Animals
;
Epithelial Cells/cytology
;
Epithelial-Mesenchymal Transition/*drug effects
;
Glycosylation End Products, Advanced/genetics/*metabolism
;
Idiopathic Pulmonary Fibrosis/metabolism
;
Pulmonary Alveoli/cytology
;
RNA, Small Interfering/genetics
;
Rats
;
Receptors, Immunologic/genetics/*metabolism
;
Smad7 Protein/genetics/*metabolism
;
Transforming Growth Factor beta/genetics/metabolism
4.Current Status of Transurethral Prostatectomy: A Korean Multicenter Study.
Dong Gyu JANG ; Changhee YOO ; Cheol Young OH ; Se Joong KIM ; Sun Il KIM ; Chun Il KIM ; Hong Sup KIM ; Jong Yeon PARK ; Do Hwan SEONG ; Yun Seob SONG ; Won Jae YANG ; In Rae CHO ; Sung Yong CHO ; Sang Hyeon CHEON ; Hyoungjune IM ; Jin Seon CHO
Korean Journal of Urology 2011;52(6):406-409
PURPOSE: We aimed to verify the current status of transurethral resection of the prostate (TURP) in Korea. MATERIALS AND METHODS: The medical records of 1,341 men who underwent TURP in 9 Korean medical centers between 2004 and 2008 were reviewed. The patients were divided into two groups according to time periods: 2004-2005 (group 1) and 2006-2008 (group 2). To verify differences in the two patient groups, age, prostate volume, indications for TURP, preoperative International Prostate Symptom Score (IPSS), and resected tissue weight were evaluated. RESULTS: The mean age of the patients was 71.2 years and the mean IPSS was 22.7. The patients' characteristics were not significantly different between the two groups. The annual cases of TURP increased over the study period. The proportion of lower urinary tract symptoms (LUTS) as an indication for TURP increased up to 58.3% in group 2 compared with 51.6% in group 1 (p=0.019). However, the proportion of patients who presented with acute urinary retention decreased from 35.5% to 30.3% with marginal statistical significance (p=0.051). Other indications such as hematuria, bladder stone, recurrent urinary tract infection, and hydronephrosis were not significantly different between the groups. The mean resected weights of the prostate were similar (17.5 g in group 1 and 18.3 g in group 2, respectively; p>0.05). CONCLUSIONS: TURP has been steadily performed in patients with benign prostatic hyperplasia and it is expected to remain constant. LUTS was the most common indication for TURP in recent years.
Hematuria
;
Humans
;
Hydronephrosis
;
Lower Urinary Tract Symptoms
;
Male
;
Medical Records
;
Prostate
;
Prostatic Hyperplasia
;
Transurethral Resection of Prostate
;
Urinary Bladder Calculi
;
Urinary Retention
;
Urinary Tract Infections
;
Weights and Measures
5.Operations about Hip in Human Immunodeficiency Virus-Positive Patients.
Jeong Joon YOO ; Sae Hyung CHUN ; Young Sam KWON ; Kyung Hoi KOO ; Kang Sup YOON ; Hee Joong KIM
Clinics in Orthopedic Surgery 2010;2(1):22-27
BACKGROUND: The number of human immunodeficiency virus (HIV)-infected patients is increasing constantly, and it is well known that there is a significantly high prevalence of osteonecrosis of the femoral head in HIV-infected patients. Therefore, it is important to develop methods that can ensure the safety of both the patients and medical personnel who participate in surgery on HIV-infected patients. Recently, the authors performed 8 procedures on 5 HIV-infected patients. This paper reports our experience. METHODS: This study examined the medical records and radiological studies of 5 HIV-infected patients who had undergone surgery around the hip joint from January, 2005 to September, 2007. During the procedures, their mean age was 38.6 years (range, 23 to 53 years) and all were male. Four of them were under an anti-retroviral therapy program. The reasons for the operations were nonunion of the femoral shaft after trauma in two patients and osteonecrosis of both femoral heads in three. One autologous bone grafting, one screw fixation with autologous bone grafting, five total hip replacement arthroplasties, and one multiple drilling were performed. All procedures were carried out according to the guidelines of HIV infection control made by the Korea Centers for Disease Control and Prevention. The mean follow-up period was 16.6 months (range, 4 to 37 months). RESULTS: The preoperative CD4 count was 130 in one patient, and 200 to 499 in the other 4. The viral loads were 15100 and 420 in two patients, and negative in the other 3. Bony union was achieved in those who had undergone autologous bone grafting. There were significant improvements in both the Harris Hip Score and functional state in those who had total hip replacement arthroplasty. There were no immediate postoperative complications, such as infection. During the follow-up period, one patient died from esophageal variceal bleeding. However, no surgery-related complications were observed in the other 4 patients. CONCLUSIONS: There were no significant complications in HIV-infected patients after the operations around the hip joint when their preoperative immunity was optimal. In addition, the safety of medical personnel can be assured when the operation is performed in line with the guidelines of HIV infection control.
Adult
;
*Arthroplasty, Replacement, Hip/adverse effects
;
Bone Transplantation
;
CD4 Lymphocyte Count
;
Femoral Fractures/complications/*surgery
;
Femur Head Necrosis/complications/*surgery
;
Fractures, Ununited/complications/*surgery
;
HIV Infections/*complications/immunology/transmission/virology
;
Humans
;
Infectious Disease Transmission, Patient-to-Professional/prevention & control
;
Male
;
Middle Aged
;
Postoperative Complications
;
Viral Load
;
Young Adult
6.A Multi-institutional Study on Histopathological Characteristics of Surgically Treated Renal Tumors: the Importance of Tumor Size.
Sun Il KIM ; Yeung Deuk CHOI ; Se Joong KIM ; Byung Ha CHUNG ; Do Hwan SEONG ; Chun Il KIM ; Sang Hyeon CHEON ; Jin Seon CHO ; Yun Seob SONG ; Young Sig KIM ; In Rae CHO ; Dong Hyeon LEE ; Ki Hak SONG ; Hong Sup KIM ; Joong Shik LEE ; Won Jae YANG ; Sung Joon HONG
Yonsei Medical Journal 2008;49(4):639-646
PURPOSE: The incidence of accidentally detected small renal tumors is increasing throughout the world. In this multi-institutional study performed in Korea, histopathological characteristics of contemporarily surgically removed renal tumors were reviewed with emphasis on tumor size. MATERIALS and METHODS: Between January 1995 and May 2005, 1,702 patients with a mean age of 55 years underwent surgical treatment at 14 training hospitals in Korea for radiologically suspected malignant renal tumors. Clinicopathological factors and patient survival were analyzed. RESULTS: Of the 1,702 tumors, 91.7% were malignant and 8.3% were benign. The percentage of benign tumors was significantly greater among those < or = 4cm (13.2%) than those > 4cm (4.5%) (p < 0.001). Among renal cell carcinoma patients, the percentage of tumors classed as stage > or = T3 was significantly less among tumors < or = 4cm (5.2%) than those > 4cm (26.8%) (p < 0.001). The percentage of tumors classed as Fuhrman's nuclear grades > or = 3 was also significantly less among tumors < or = 4cm (27.3%) than tumors > 4cm (50.9%) (p < 0.001). The 5-year cancer-specific survival rate was 82.7%, and T stage (p < 0.001), N stage (p < 0.001), M stage (p = 0.025), and Fuhrman's nuclear (p < 0.001) grade were the only independent predictors of cancer-specific survival. CONCLUSION: In renal tumors, small tumor size is prognostic for favorable postsurgical histopathologies such as benign tumors, low T stages, and low Fuhrman's nuclear grades. Our observations are expected to facilitate urologists to adopt function-preserving approach in the planning of surgery for small renal tumors with favorable predicted outcomes.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Female
;
Humans
;
Kidney Neoplasms/classification/*pathology/*surgery
;
Male
;
Middle Aged
;
Neoplasm Staging
7.Lowering Prostate-specific Antigen Threshold for Prostate Biopsy in Korean Men: Impact on the Number Needing Biopsy.
Jin Seon CHO ; Sun Il KIM ; Se Joong KIM ; Young Sig KIM ; Chun Il KIM ; Hong Sup KIM ; Do Hwan SEONG ; Yun Seob SONG ; Dong Hyeon LEE ; Won Jae YANG ; Sang Hyeon CHEON ; Kang Su CHO ; In Rae CHO ; Byung Ha CHUNG ; Young Deuk CHOI ; Hyoungjune IM ; Sung Joon HONG
Korean Journal of Urology 2008;49(2):118-121
PURPOSE: We examined the effect of lowering prostate-specific antigen (PSA) threshold on the number of Korean men requiring a prostate biopsy. MATERIALS AND METHODS: We evaluated men who had serum PSA levels tested at routine physical check-ups between 1999 and 2005 at 11 domestic hospitals. Men with PSA> or =10ng/ml or patients with prostate cancer were excluded. A total of 45,074 men(aged 50 to 79 years) were enrolled and split into three age groups: 50-59 years, 60-69 years, and 70-79 years. For each age group, we calculated the number and proportion of men whose PSA level exceeded potential biopsy thresholds: 2.5ng/ml, 3.0ng/ml, and 4.0ng/ml. Results were extrapolated to the 4.992 million men older than 50 years old, or 21.3% of the Korean male population in 2005. RESULTS: The number of biopsy candidates at the threshold of 4.0ng/ml, 3.0ng/ml, and 2.5ng/ml were 1,321(2.9%), 2,248(5.4%), and 3,577(7.9%), respectively. Extrapolating to the male population in Korea, lowering the PSA threshold from 4.0ng/ml to 3.0 or 2.5ng/ml would increase the number of men needing biopsy by 1.75 and 2.49 times, respectively. CONCLUSIONS: Lowering the PSA threshold would increase the number of men receiving prostate biopsy despite the low reference age for PSA in Korea. Considering the low incidence of prostate cancer, physicians should be careful in altering the PSA threshold.
Biopsy
;
Humans
;
Incidence
;
Korea
;
Male
;
Prostate
;
Prostate-Specific Antigen
;
Prostatic Neoplasms
8.Predictive Factors of the Long-term Medical Treatment Failure in Benign Prostatic Hyperplasia.
Kyung Seop LEE ; Min Eui KIM ; Se Joong KIM ; Han Kwon KIM ; Hong Sup KIM ; Chun Il KIM ; Tae Gyun KWON ; Hyun Yul RHEW ; Kwangsung PARK ; Dong Soo PARK ; Jong Kwan PARK ; Jae Shin PARK ; Gyung Tak SUNG ; Tae Hee OH ; Sang Min YOON ; Young Goo LEE ; In Rae CHO ; Jin Seon CHO ; Jaeil CHUNG ; Hee Chang JUNG ; Sung Hoo HONG ; Jae Seog HYUN
Korean Journal of Urology 2008;49(9):826-830
PURPOSE: The aim of this study was to identify the clinical baseline factors that affect failure of medical treatment(and especially surgical treatment) for benign prostatic hyperplasia(BPH) in spite of long-term medication. MATERIALS AND METHODS: 802 men who were over 50 years of age with BPH were enrolled for this study. Patients were allocated to a medication group and a surgical treatment group(after having at least a 12 month duration of medication). We compared the differences between the two groups for their initial International Prostate Symptom Score(IPSS), the uroflowmetry, the prostate volume, the postvoid residual urine and the serum prostate specific antigen(PSA). RESULTS: 397 patients had surgical treatment following medication due to BPH progression(acute urinary retention, aggravating LUTS) and 405 patients were given maintenance medical treatment during follow-up. Statistically significant differences were found in the IPSS(23.3+/-6.6 vs. 12.7+/-8.4), the prostate volume(53.5+/-28.1ml vs. 38.3+/-12.6ml), the maximal flow rate(7.8+/-4.7ml/sec vs. 12.7+/-5.4ml/sec), the postvoid residual urine volume(92.7+/-144.4cc vs. 36.5+/-147.1cc), and the PSA(6.1+/-7.6ng/ml vs. 2.8+/- 2.8ng/ml) between the surgical and medication groups. According to the area under the curve(AUC), the IPSS, prostate volume, maximal flow rate, postvoid residual urine volume and PSA are important in descending order. According to the receiver operating characteristic(ROC) curve- based prediction of the surgical intervention, the best cutoff value for the IPSS and prostate volume were 17(area under ROC curve: 0.83) and 40ml (area under ROC curve: 0.68), respectively. Conclusions: The results show that BPH patients with more severe IPSS (>or=17) and a larger prostate volume(>40ml) have a higher risk of surgical intervention, and this suggests that the IPSS and prostate volume may be useful predictors at the initial visit for surgical intervention.
Follow-Up Studies
;
Humans
;
Male
;
Prostate
;
Prostatic Hyperplasia
;
Treatment Failure
;
Urinary Retention
9.Effectiveness and Tolerance of Duodenoscopic Bowel Preparation for Colonoscopy.
Ju Hee MAENG ; Bong Min KO ; Moon Sung LEE ; Hyun Sik NA ; Hyo Joong YOON ; Sang Hun HAN ; Sang Gyune KIM ; Su Jin HONG ; Chang Beom RYU ; Young Seok KIM ; Jong Ho MOON ; Jin Oh KIM ; Joo Young CHO ; Joon Seong LEE ; Chan Sup SHIM ; Boo Sung KIM
The Korean Journal of Gastroenterology 2007;50(2):78-83
BACKGROUND/AIMS: Bowel preparation for colonoscopy remains an unpleasant experience because oral solutions have unpleasant tastes and may provoke abdominal pain, nausea, vomiting, and sleep disturbance. Duodenoscopic bowel preparation is an alternative method for patients who are unwilling to take oral preparation solution or for those who are supposed to have both gastroscopic and colonoscopic examination on the same day. We assessed the effectiveness and tolerance of duodenoscopic bowel preparation. METHODS: Patients in group OA (orally administered) ingested 45 mL of sodium phosphate (NaP) in the evening before the day of procedure and in the morning on the day of colonoscopy, whereas patients in group EA (endoscopically administered) were prepared for the procedure by duodenoscopic infusion of 90 mL of NaP diluted with 180 mL of water into the second portion of the duodenum. After 4 hours, we assessed the overall quality of colonic cleansing, using a range of excellent to inadequate. The patients completed a questionnaire on their preparation-associated symptoms, tolerance, and preference. RESULTS: In group EA, sleep disturbance (p<0.05) and nausea (p<0.05) occurred less frequently than in group OA. Overall, the tolerance rating for preparation was higher in group EA. However, the quality of colonic cleansing and cecum intubation time was not different between the two groups. Patients in group EA who had ingested NaP in the past preferred duodenoscopic bowel preparation. CONCLUSIONS: Duodenoscopic bowel preparation may play a role in colonic cleansing especially for patients who are scheduled to undergo gastroscopic and colonoscopic examination on the same day and for those who are unwilling to ingest NaP.
Administration, Oral
;
Adult
;
Aged
;
Cathartics/*administration & dosage/adverse effects
;
*Colonoscopy
;
*Duodenoscopy
;
Female
;
Humans
;
Image Enhancement
;
Irrigation
;
Male
;
Middle Aged
;
Phosphates/*administration & dosage/adverse effects/chemistry
;
Questionnaires
;
Treatment Outcome
10.Effectiveness and Tolerance of Duodenoscopic Bowel Preparation for Colonoscopy.
Ju Hee MAENG ; Bong Min KO ; Moon Sung LEE ; Hyun Sik NA ; Hyo Joong YOON ; Sang Hun HAN ; Sang Gyune KIM ; Su Jin HONG ; Chang Beom RYU ; Young Seok KIM ; Jong Ho MOON ; Jin Oh KIM ; Joo Young CHO ; Joon Seong LEE ; Chan Sup SHIM ; Boo Sung KIM
The Korean Journal of Gastroenterology 2007;50(2):78-83
BACKGROUND/AIMS: Bowel preparation for colonoscopy remains an unpleasant experience because oral solutions have unpleasant tastes and may provoke abdominal pain, nausea, vomiting, and sleep disturbance. Duodenoscopic bowel preparation is an alternative method for patients who are unwilling to take oral preparation solution or for those who are supposed to have both gastroscopic and colonoscopic examination on the same day. We assessed the effectiveness and tolerance of duodenoscopic bowel preparation. METHODS: Patients in group OA (orally administered) ingested 45 mL of sodium phosphate (NaP) in the evening before the day of procedure and in the morning on the day of colonoscopy, whereas patients in group EA (endoscopically administered) were prepared for the procedure by duodenoscopic infusion of 90 mL of NaP diluted with 180 mL of water into the second portion of the duodenum. After 4 hours, we assessed the overall quality of colonic cleansing, using a range of excellent to inadequate. The patients completed a questionnaire on their preparation-associated symptoms, tolerance, and preference. RESULTS: In group EA, sleep disturbance (p<0.05) and nausea (p<0.05) occurred less frequently than in group OA. Overall, the tolerance rating for preparation was higher in group EA. However, the quality of colonic cleansing and cecum intubation time was not different between the two groups. Patients in group EA who had ingested NaP in the past preferred duodenoscopic bowel preparation. CONCLUSIONS: Duodenoscopic bowel preparation may play a role in colonic cleansing especially for patients who are scheduled to undergo gastroscopic and colonoscopic examination on the same day and for those who are unwilling to ingest NaP.
Administration, Oral
;
Adult
;
Aged
;
Cathartics/*administration & dosage/adverse effects
;
*Colonoscopy
;
*Duodenoscopy
;
Female
;
Humans
;
Image Enhancement
;
Irrigation
;
Male
;
Middle Aged
;
Phosphates/*administration & dosage/adverse effects/chemistry
;
Questionnaires
;
Treatment Outcome

Result Analysis
Print
Save
E-mail